✦ LIBER ✦

Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: A review of three phase II studies

✍ Scribed by Ralph C Schimmer; Frieder Bauss

Book ID: 117321522
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 849 KB
Volume: 25
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(03)90005-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histomorphometric evaluation of daily an

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

✍ R.R. Recker; R.S. Weinstein; C.H. Chesnut; R.C. Schimmer; P. Mahoney; C. Hughes; 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

Ibandronate: A Comparison of Oral Daily

Ibandronate: A Comparison of Oral Daily Dosing Versus Intermittent Dosing in Postmenopausal Osteoporosis

✍ B. J. Riis; J. Ise; T. Von Stein; Y. Bagger; C. Christiansen 📂 Article 📅 2001 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 328 KB

Effects of intermittent intravenous iban

Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study

✍ Robert R. Recker; Louis-George Ste-Marie; Bente Langdahl; Edward Czerwinski; Ber 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Effect of rectal salmon calcitonin treat

Effect of rectal salmon calcitonin treatment on bone mass and bone turnover in patients with established postmenopausal osteoporosis: A 1-year crossover study

✍ Stefano Gonnelli; Donato Agnusdei; Angelo Camporeale; Rossella Palmieri; Carlo G 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Effect of intranasal salmon calcitonin t

Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study

✍ K. Overgaard 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 578 KB

We examine the dose-related effect of intranasal salmon calcitonin (sCT) on the early postmenopausal bone loss and bone turnover; a 2-year, prospective, randomized, double-blind, placebo-controlled study was carried out with 134 healthy women who had passed a natural menopause within 6 months to 3 y

Effects of Oral Ibandronate Administered

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

✍ Charles H Chesnut III; Arne Skag; Claus Christiansen; Robert Recker; Jacob A Sta 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 196 KB